Skip to main content

Month: July 2020

Genocea Provides Second Quarter 2020 Corporate Update

Upcoming GEN-009 data update planned for July 30th at 8 a.m. EDTFiled IND application for GEN-011 and is working with the FDA to provide additional informationPrivate Placement with Leading Life Science Investment FundsConference call today at 8:30 a.m. EDTCAMBRIDGE, Mass., July 23, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today reported its operating and financial results for the second quarter ended June 30, 2020. Genocea had an active and productive second quarter, demonstrating important progress across the Company:GEN-009On July 30, 2020, the Company plans to present initial clinical data on the first 5 patients from Part B with Dr. Maura L. Gillison, MD, PhD, Professor of Medicine, Department of Thoracic/Head and Neck...

Continue reading

American Airlines Takes Strategic Action in Second Quarter to Prioritize Safety, Flexibility and Efficiency in Response to COVID-19

FORT WORTH, Texas, July 23, 2020 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) today reported its second-quarter 2020 financial results, including:Second-quarter pretax loss of $2.7 billion. Excluding net special items1, second-quarter pretax loss of $4.3 billion.Second-quarter net loss of $2.1 billion, or ($4.82) per share. Excluding net special items1, second-quarter net loss of $3.4 billion, or ($7.82) per share.Boosted available liquidity by a net $3.6 billion in the quarter through offerings of common stock, convertible bonds and secured bonds.Ended second quarter with approximately $10.2 billion of available liquidity. Additionally, signed term sheet with the U.S. Department of the Treasury for $4.75 billion secured loan, which is expected to close in the third quarter, and announced two senior secured note...

Continue reading

AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand

Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties  Collaboration further advances the development of ciraparantagWALTHAM, Mass. and AMSTERDAM, The Netherlands, July 23, 2020 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Norgine B.V., a leading European specialist pharmaceutical company, today announced they have entered into an exclusive licensing agreement to develop and commercialize ciraparantag in Europe, Australia and New Zealand. Ciraparantag is in development for use in patients treated with direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) when reversal of the anticoagulant effect of these products is needed for emergency surgery, urgent procedures or due...

Continue reading

Manhattan Bridge Capital, Inc. Reports Second Quarter 2020 Results

GREAT NECK, N.Y., July 23, 2020 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that its total revenues for the three months ended June 30, 2020 were approximately $1,741,000 compared to approximately $1,779,000 for the three months ended June 30, 2019, a decrease of $38,000, or 2.1%. The decrease in revenues was primarily attributable to lower interest rates and origination points charged on loans due to market conditions and intense competition from other lenders, as well as lower demand for new loans resulting from the COVID-19 pandemic. For the three months ended June 30, 2020 and 2019, approximately $1,490,000 and $1,487,000, respectively, of our revenues were attributable to interest income on secured commercial loans that we offer to small businesses, and approximately $251,000 and $292,000,...

Continue reading

Reliance Steel & Aluminum Co. Reports Second Quarter 2020 Financial Results

– Strong gross profit margin of 30.4%– EPS of $1.24, non-GAAP EPS of $1.36– Generated cash flow from operations of $475.7 million– Declared quarterly dividend of $0.625 per shareLOS ANGELES, July 23, 2020 (GLOBE NEWSWIRE) — Reliance Steel & Aluminum Co. (NYSE: RS) today reported its financial results for the second quarter ended June 30, 2020 (in millions, except tons which are in thousands and per share amounts).Management Commentary“The strength and resiliency of our business model produced solid results during an extraordinary and extremely challenging quarter. Because we support many customers deemed essential businesses, our tons sold declined only 17.5% compared to the first quarter of 2020,” said Jim Hoffman, President and Chief Executive Officer of Reliance. “We maintained a strong gross profit...

Continue reading

Nanotech Expands Thurso, Quebec Production Facility to Accommodate Growth

VANCOUVER, British Columbia, July 23, 2020 (GLOBE NEWSWIRE) — Nanotech Security Corp. (TSXV: NTS) (OTCQX: NTSFF) (“Nanotech” or the “Company”), a leader in the development of secure and memorable nano-optic security features used in the government and banknote and brand protection markets, announces the expansion of its Thurso production facility.Nanotech has invested over $1.5 million in the expansion of its 28,000 sq. ft. highly secure production facility, with improvements to increase production capacity and expand overall capabilities. As part of the expansion, Nanotech has built an ISO 7 level clean room for advanced equipment and is adding UV recombination capabilities, as well as a proprietary silver spray system and a new water-based de-metallization machine.The expansion also includes upgrades to utilities and modifications...

Continue reading

Hershey Reports Second-Quarter 2020 Financial Results; Provides 2020 Business Update

HERSHEY, Pa., July 23, 2020 (GLOBE NEWSWIRE) — The Hershey Company (NYSE: HSY) today announced net sales and earnings for the second quarter ended June 28, 2020.Second-Quarter 2020 Financial Results Summary1Consolidated net sales of $1,707.3 million, a decrease of 3.4%.Organic, constant currency net sales decreased 3.5%.The net impact of acquisitions and divestitures on net sales was a 0.8 point benefit, while foreign currency exchange was a 0.7 point headwind.Reported net income of $268.9 million, or $1.29 per share-diluted, a decrease of 12.8%.Adjusted earnings per share-diluted of $1.31, flat versus the same period a year ago.1 All comparisons for the second quarter of 2020 are with respect to the second quarter ended June 30, 2019“We delivered profitable sales growth in North America in the second quarter despite the increased...

Continue reading

Annovis Bio CEO Appears on Executive Leaders Radio Program

BERWYN, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph.D., will appear on the Executive Leaders Radio program, airing nationally on Radio America (www.radioamerica.org) on July 26, 2020 at 11 a.m. ET.Executive Leaders Radio is the leading business weekly radio show in the Mid-Atlantic States and broadcast nationally on over 125 terrestrial and internet radio stations. Executive Leaders Radio conducts “elite interviews” of prominent CEOs, CFOs, and Presidents focusing on “what makes people tick.” The program airing on July 26 features CEOs of life sciences companies and explores the connections...

Continue reading

Exterran Corporation Announces Second Quarter 2020 Earnings Release and Conference Call Schedule

HOUSTON, July 23, 2020 (GLOBE NEWSWIRE) — Exterran Corporation (NYSE: EXTN) (“Exterran” or the “Company”) today announced that it will release its second quarter 2020 results on Monday, August 10th, 2020 before the market opens. The Company has scheduled a conference call for Monday, August 10th, 2020 at 10 a.m. Central Time to discuss the results. The call will be broadcast live over the Internet. Investors may participate either by phone or audio webcast.About Exterran CorporationExterran Corporation (NYSE: EXTN) is a global systems and process company offering solutions in the oil, gas, water and power markets. We are a provider of natural gas processing and treatment and compression products and services, providing critical midstream infrastructure solutions to customers throughout the world. Exterran Corporation is headquartered...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.